Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Earnings

Review historical estimates and see whether a company has beaten or missed expectations.

Last Close
Jun 14 04:00PM ET
27.46
Dollar change
-0.40
Percentage change
-1.44
%
CategoryGlobal or ExUS Equities - Industry Sector Asset TypeEquities (Stocks) TagsGlobal Return% 1Y- Shs Outstand Perf Week0.07%
SponsorTema ETF Type Tagsequity Return% 3Y- Total Holdings48 Perf Month-0.98%
Fund Family Bond Type Tagshealthcare Return% 5Y- AUM29.33M Perf Quarter1.18%
Index- Average Maturity Tags- Return% 10Y NAV% Perf Half Y8.23%
Index Weighting Commodity Type Tags- Return% SI NAV/sh Perf Year-
Active/Passive Quant Type Tags- Flows% 1M56.19% 52W Range21.46 - 29.16 Perf YTD4.03%
Dividend TTM0.13 (0.49%) ESG Type Tags- Flows% 3M58.56% 52W High-5.83% Beta-
Dividend Ex-DateDec 13, 2023 Dividend Type Sector/Theme Flows% YTD60.80% 52W Low27.98% ATR (14)0.55
Expense0.75% Structure Type Region Flows% 1Y RSI (14)53.23 Volatility2.33% 1.86%
Option/ShortNo / No Growth/Value Dev/Emerg Flows% 3Y Rel Volume1.40 Prev Close27.86
Inverse/Leveraged Market Cap Currency Flows% 5Y Avg Volume7.15K Price27.46
SMA200.66% SMA502.16% SMA2006.88% Trades Volume10,016 Change-1.44%
Tema Oncology ETF seeks to provide long-term growth. Under normal circumstances, the fund seeks to achieve its investment objective by investing at least 80% of its net assets, which include borrowings for investment purposes, in publicly listed companies that derive at least 50% of revenues from oncology. The fund is non-diversified.